Sofgen Pharma | About Us

Melissa Angelini

Interim Chief Executive Officer

Ms. Angelini is a seasoned executive with over 18 years of experience in capital markets, corporate finance, and investor relations within healthcare and pharmaceutical industries. Ms. Angelini has extensive experience with clients in Latin American countries including Brazil, Mexico, Argentina, Uruguay, Chile, Colombia and Peru, leading financial transactions and capital markets initiatives.

Prior to Procaps, Ms. Angelini served as Innovation & Investor Relations Officer at Blau Farmacêutica, a Brazilian multinational pharmaceutical company, where she led the IPO at B3 in Brazil, and as LATAM Head of Alliance Management & Investor Relations at GBT Grupo Biotoscana, where she co-led the company’s 2017 dual listing IPO, in Brazil and Luxembourg, and played a key role in its eventual acquisition by Knight Therapeutics. Ms. Angelini received a B.S. in International Relations from Universidad de Palermo and is currently pursuing an Executive MBA at Kellogg School of Management.

Luis Palacios

Chief Commercial Officer CCO

Luis Alberto Palacios Aragon, born in Peru, graduated from the Universidad del Pacifico with a Business Management degree. He later received a Master’s degree in Marketing and Business Management from the American University of Paraguay and leadership training at Kellogg Business School. He has 35 years of varied and extensive experience in the Latin American pharmaceutical sector, executing different commercial roles, managing clients, especially health professionals from different Latin American countries.

For 6 years, he has served Sofgen Pharma, leading commercial management and international marketing for the Pharma Business Management in Colombia. In 2019 he assumed the challenge of being the Corporate Vice President of International Marketing and Research and Development, constantly promoting the development of science and innovation.

Claudio Colombano

Executive Director of Manufacturing Operations & Quality

Mr. Colombano is an executive with more than 30 years of extensive and distinguished experience in the pharmaceutical industry, leading operations and commercial leadership processes.

He has a strong track record in building high-performance teams and managing manufacturing facilities across LATAM, Vietnam, and Canada. Mr. Colombano holds a Bachelor’s degree in Chemistry from the University of Buenos Aires, a Ph.D. in Chemistry from the same institution, and a Postdoctoral Fellowship in Molecular Photobiology from the Max Planck Institute in Germany.

Daniel Bernal

Interim CFO

Daniel Bernal has 29+ years of experience working in a host of multinational and national professional services firms. Prior to his position as Managing Partner at Moore Colombia, from 2020 to 2022, Mr. Bernal was a Managing Partner at Audit Business Enterprise, a firm that provides auditing and business process outsourcing services, and from 1998 to 2020, an Audit Partner at Deloitte & Touche, a professional services firm.

Mr. Bernal holds a degree in Public Accounting from Santo Tomas de Aquino University and is a certified public accountant in Colombia. Additionally, Mr. Bernal holds certificates in IFRS standards, international auditing standards, and PCAOB accounting standards. Mr Bernal is a Managing Partner of Moore Colombia, a consulting firm that provides specialized consulting services across a wide range of professional services, a position he has held since 2022. In his role as a Managing Partner, Mr. Bernal is responsible for the design and control of Moore Colombia’s operation of each of the professional service areas provided.